|
π
|
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
14 auth.
M. Alexander,
A. K. Loomis,
J. van der Lei,
T. Duarte-Salles,
D. Prieto-Alhambra,
D. Ansell,
A. Pasqua,
F. Lapi,
P. Rijnbeek,
M. Mosseveld,
...
Dawn Waterworth,
Stuart Kendrick,
N. Sattar,
W. Alazawi
|
7 |
2019 |
7
π
|
|
π
|
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
17 auth.
M. Alexander,
A. K. Loomis,
J. Fairburn-Beech,
Johan van der Lei,
T. Duarte-Salles,
D. Prieto-Alhambra,
D. Ansell,
A. Pasqua,
F. Lapi,
P. Rijnbeek,
...
M. Mosseveld,
P. Avillach,
P. Egger,
Stuart Kendrick,
Dawn Waterworth,
N. Sattar,
W. Alazawi
|
7 |
2018 |
7
π
|
|
π
|
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
13 auth.
V. Hegade,
Stuart Kendrick,
R. Dobbins,
Sam Miller,
D. Thompson,
Duncan B. Richards,
J. Storey,
G. Dukes,
M. Corrigan,
R. Elferink,
...
U. Beuers,
G. Hirschfield,
David E. J. Jones
|
7 |
2017 |
7
π
|
|
π¦
|
Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis
7 auth.
Stuart Kendrick,
G. O'boyle,
J. Mann,
M. Zeybel,
J. Palmer,
David E. J. Jones,
...
C. Day
|
7 |
2010 |
7
π¦
|
|
π
|
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
34 auth.
M. Yuen,
S. Lim,
R. PleΕniak,
K. Tsuji,
H. Janssen,
C. Pojoga,
A. Gadano,
C. Popescu,
T. Stepanova,
T. Asselah,
Gheorghe Diaconescu,
H. Yim,
J. Heo,
E. Janczewska,
Alexander Wong,
...
N. Idriz,
M. Imamura,
G. Rizzardini,
K. Takaguchi,
P. Andreone,
M. Arbune,
J. Hou,
Sung-Jae Park,
A. VΓ’ΘΔ,
J. Cremer,
R. Elston,
Tamara LukiΔ,
Geoff Quinn,
L. Maynard,
Stuart Kendrick,
H. Plein,
F. Campbell,
M. Paff,
D. Theodore
|
6 |
2022 |
6
π
|
|
π
|
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
16 auth.
Marie P Boyle,
D. Tiniakos,
J. Schattenberg,
V. Ratziu,
E. Bugianessi,
S. Petta,
C. Oliveira,
O. Govaere,
R. Younes,
S. McPherson,
...
P. Bedossa,
M. Nielsen,
M. Karsdal,
D. Leeming,
Stuart Kendrick,
Q. Anstee
|
6 |
2019 |
6
π
|
|
π
|
The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility
11 auth.
L. Wong,
H. Fisher,
D. Stocken,
S. Rice,
A. Khanna,
M. Heneghan,
...
Y. Oo,
G. Mells,
Stuart Kendrick,
J. Dyson,
David E. J. Jones
|
5 |
2018 |
5
π
|
|
π
|
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.
10 auth.
V. Hegade,
G. Mells,
H. Fisher,
Stuart Kendrick,
J. DiBello,
K. Gilchrist,
...
G. Alexander,
G. Hirschfield,
R. Sandford,
David E. J. Jones
|
5 |
2019 |
5
π
|
|
π
|
Clinical quantification of the integrin Ξ±vΞ²6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
20 auth.
P. Lukey,
C. Coello,
R. Gunn,
C. Parker,
Frederick J Wilson,
A. Saleem,
Nadia Garman,
Maria Costa,
Stuart Kendrick,
M. Γnega,
...
A. Kangβombe,
Allan Listanco,
James Davies,
Joaquim Ramada-Magalhaes,
Sara Moz,
W. Fahy,
T. Maher,
G. Jenkins,
J. Passchier,
R. Marshall
|
5 |
2019 |
5
π
|
|
π
|
Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin Ξ±vΞ²6 inhibitor, in healthy participants
13 auth.
C. Maden,
D. Fairman,
M. Chalker,
M. Costa,
W. Fahy,
Nadia Garman,
P. Lukey,
T. Mant,
S. Parry,
J. Simpson,
...
R. Slack,
Stuart Kendrick,
R. Marshall
|
5 |
2018 |
5
π
|
